Immune Mediated Regression

This version of the course is no longer available.
Need multiple seats for your university or lab? Get a quote
The page below is a sample from the LabCE course Human Papillomavirus (HPV) and Molecular Testing for Cervical Cancer. Access the complete course and earn ASCLS P.A.C.E.-approved continuing education credits by subscribing online.

Learn more about Human Papillomavirus (HPV) and Molecular Testing for Cervical Cancer (online CE course)
Immune Mediated Regression

Abnormal cervical tissue is described using categories of cervical intraepithelial neoplasia (CIN). Categories are CIN 1, CIN 2, and CIN 3; increasing number designates the thickness of cervical lining with abnormal cells. CIN 3 is considered precancerous.

Host immune response to the virus resolves most HPV lesions, especially genital condolymas and CIN 1 lesions. Neither of these is precancerous. This regression ocassionally occurs with CIN 2, but rarely occurs with CIN 3. If the CIN does not regress, high-grade squamous intraepithelial lesions (HSIL) develop. HSIL may progress to invasive carcinoma, typically in older individuals.